Agenus | AGEN - 税前利润



金融业
股票价格
USD
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 2.98B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


税前利润 更改 日
AbbVie USD 7.61B 2.04B 2026-06
Agenus USD 39.21M 49.82M 2026-03
Amgen USD 2.08B 570M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Celldex Therapeutics USD -78.68M 2.63M 2026-03
CSL USD 2.61B 1.21B 2025-12
Eli Lilly USD 8.85B 583.8M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Glaxosmithkline GBP 2.14B 312M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Intrexon USD -60.48M 27.09M 2024-06
J&J USD 8.66B 839M 2026-06
Jiangsu Hengrui CNY 2.4B 161.31M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Merck EUR 869M 468M 2026-03
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Novavax USD 17.9M 220.94M 2025-12
Pfizer USD -653M 5.84B 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Veracyte USD 26.52M 3.45M 2026-06